Blog - Page 2880 of 5596

TuesdayAug 06, 2013 9:45 am

Epazz, Inc. (EPAZ) One Step Closer to Executing Second Spin-off Project

Epazz, a provider of cloud-based business software solutions, is rapidly advancing its second spin-off project, Human Mobile Power, and is currently working with a patent attorney to file for a patent pending status on the device. Project Human Power is a project to develop a mobile power device for iPhone and other smartphones that allows users to charge their phone without the need for an outlet or second battery. Because the product is not directly in line with Epazz's core business, the company believes the project creates opportunity for a spin-off to spur growth and shareholder value. Epazz’s strategy is…

TuesdayAug 06, 2013 9:33 am

Dragon Capital Group Corp. (DRGV) Selected by Shanghai City North Gas Company for Gas Valve Grouping Project

Dragon Capital Group, a leading holding company of emerging high-tech companies in China, today announced that Shanghai City North Gas Company, Ltd. has chosen its Shanghai Yazheng Information Technology Company ("Yazheng") subsidiary to carry out a gas valve grouping system project based on Yazheng's ARC/INFO Gas Information System. The project is designed to improve the overall efficiency of a portion of Shanghai City North's gas pipeline network. Its main focus is on setting up and optimizing the grouping of the valve network in order to reduce the number of customers affected by any pipe network failure and to quickly determine…

TuesdayAug 06, 2013 9:30 am

ChromaDex Corp. (CDXC) Acquires Worldwide Patent Rights for pTeroPure® Pterostilbene for Skin Care Applications

ChromaDex, a natural products company that provides proprietary, science-based solutions and ingredients for a variety of industries, has licensed from Green Molecular S.L. the exclusive worldwide patent rights pertaining to pharmaceutical and cosmetic preparations of pterostilbene for topical application for prevention and/or treatment of skin diseases, damage, or injuries, including those linked to aging and sun exposure. Following this most recent acquisition, ChromaDex’ patent portfolio consists of eight patents and patents pending relating to pterostilbene. This is the company’s second acquisition made of worldwide patent rights for pTeroPure®, ChromaDex's branded nature identical form of pterostilbene, associated with skincare. “We intend…

TuesdayAug 06, 2013 9:19 am

International Stem Cell Corp. (ISCO) Receives Coverage from Crystal Research Associates

Crystal Research Associates, an independent research firm that has provided institutional-quality research on small-cap and mid-cap companies for the past decade, has issued an Executive Informational Overview® on International Stem Cell Corporation. The complete 72-page report is available on Crystal Research Associates' website at www.crystalra.com. International Stem Cell Corporation is a biotechnology company focused on therapeutic applications of human parthenogenetic stem cells (hpSCs) to treat diseases of the brain, liver, and eye, as well as on the development and commercialization of biomedical products. According to the company, hpSC is the only histocompatible stem cell platform capable of generating stem cell…

TuesdayAug 06, 2013 8:39 am

OxySure Systems, Inc. (OXYS) Engages DTG to Enhance Corporate Communications

Today before the opening bell, OxySure announced that it has enlisted the investor relations (IR) and social media relations (SMR) services of DreamTeamGroup (DTG). Leveraging a network of investor-oriented sites and full team of dedicated professionals, DTG broadens the influence of publicly traded companies and enhances their ability to attract growth capital as well as improve shareholder value. "Leveraging numerous patents and patents pending, OxySure has demonstrated its ability and dedication to consistently create new products and opportunities, and build company value," stated Sherri S. Franklin, Director of Marketing at DTG. "OxySure has positioned itself to capitalize on a wealth…

MondayAug 05, 2013 2:32 pm

OxySure® Systems Inc. (OXYS) is “One to Watch”

OxySure® Systems is a medical technology company focused on developing, manufacturing, and distributing specialty respiratory and medical solutions. The company has developed a unique platform technology that instantly creates medically pure oxygen from two dry, inert powders, allowing oxygen to be delivered on demand. This cutting-edge technology has already been granted FDA-approved for commercial sale. The company is targeting multiple enormous end markets with no direct competition. OxySure initially plans to focus on the 102,265 educational campuses, 350,735 manufacturing facilities, 350,000 churches, 12 million recreational vehicles (RVs), 8 million boats and yachts, 950,000 restaurants, and hundreds of thousands of other…

MondayAug 05, 2013 2:02 pm

StreamTrack, Inc. (STTK) Leads Entertainment Industry Revolution

It’s impossible not to recognize the major shift occurring in personal consumer entertainment, away from the costs and limitations of cable and satellite to the greater flexibility of the Internet and related digital technology. The cable industry alone is a $100 billion industry, so it represents a huge potential for young companies now grabbing chunks of old-world market share. One of those companies is StreamTrack, a California based digital media and technology services company that provides audio and video streaming, and associated patent-pending advertising systems. The company’s RadioLoyalty platform serves worldwide Internet and terrestrial radio stations and content providers. The…

MondayAug 05, 2013 12:54 pm

PITOOEY!, Inc. (PTOO) – Creating Commerce Convenience, One Consumer at a Time

Moving requires a barrage of adjustment, from finding the daily necessities packed in “one of those boxes” in stacks throughout the house, to navigating local amenities for shopping, entertainment, and business. Whether the user is new to an area, looking for a specific place in their hometown, or traveling to an unfamiliar city, PITOOEY!’s mobile app was developed to help consumers locate businesses and vendors in desired proximity while providing those same businesses with a way to engage with interested consumers. The app allows users to create a personalized list of their favorite businesses via a search and free subscribe…

MondayAug 05, 2013 11:47 am

VistaGen Therapeutics, Inc. (VSTA) Aims to Revive Once-Promising Drug Candidates with Latest Medicinal Technology

VistaGen is a biotech company applying human pluripotent stem cell technology for drug rescue and regenerative cell therapy. The company’s drug rescue program involves combining this stem cell technology with the latest medicinal chemistry to create new chemical variants of once-promising small molecule drug candidates that were discontinued prior to market approval due to unexpected safety concerns of the heart and/or liver. VSTA is primarily focused on leveraging its Human Clinical Trials in a Test Tube™ platform to assess heart and liver toxicity of new drug candidates in an accelerated and higher precision means versus currently used in vitro techniques…

MondayAug 05, 2013 11:14 am

NanoTech Entertainment, Inc. (NTEK) Further Reduces Share Count, Boosts Shareholder Value

NanoTech Entertainment just announced that it has completed the third phase of an ongoing plan to decrease the number of outstanding shares. The NanoTech Board of Directors had previously authorized a program under which the company has already retired 221 million shares of its outstanding common stock. At the 2013 shareholders meeting Director Ted Campbell announced a continuation of the effort. Campbell stated, “Early on, NanoTech had leveraged its ability to finance the company through a series of convertible debentures. Now that we have moved out of the R&D phase and have several products gaining traction in the market, we…

Site Search

Company Search